*By Carlo Versano* The competition is on for new medicinal marijuana licenses in New Jersey after Democratic Gov. Phil Murphy prioritized cannabis production when he took office. The CEO of one potential licensee, Moxie, thinks the state has "passed the tipping point" for accepting medical pot at the state level. Jordan Lams, founder and CEO of the medicinal marijuana producer, told Cheddar as he awaited news on whether his company had been awarded one of the licenses that Moxie has a fully built-out, 16-acre farm and greenhouse operation at the ready ー which would help New Jersey get its operations up to scale quickly. "The state can count on us to do what we say we will," he said. Lams praised Gov. Murphy for "taking ownership" of medical marijuana policy after it had languished under previous administrations. There is now so much pent-up demand from patients Lams said, that the state has concerns over shortages. The license that Moxie hopes to win is a fully-integrated, "seed-to-sale" license, though Lams said he will also apply for licenses to just grow and process, if this one is not granted. Lams, who started a career in medical marijuana after his younger sister died of leukemia, now advocates for responsible regulations in the nascent cannabis industry. He said he's seeing a market that's "developing every day." "Every day someone who never would have touched this before is really coming into the marketplace. It's global at this point." For full interview [click here](https://cheddar.com/videos/moxie-vies-for-nj-medicinal-marijuana-license).

Share:
More In Business
Fed's Powell Was Tricked by Fake Call From Russia Pranksters
Federal Reserve Chair Jerome Powell was tricked into an extended phone call in January with Russian pranksters posing as Ukrainian President Volodymyr Zelenskyy, during which Powell appeared to discuss the economic impact of interest rate hikes.
Amazon Q1 Revenue, Profit Grow but Cloud Unit a Concern
Amazon on Thursday reported stronger-than-expected revenue and profits for the first quarter, sending its stocks higher in after-hours trading. But its prices took a dip in the evening amid concerns about a continued slowdown in the company's profitable cloud computing unit AWS.
Load More